Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 5, 2008, Pages

  Watanabe, Atsushi ^a   Higami, Tetsuya ^a   Ohori, Syunsuke ^a   Koyanagi, Tetsuya ^a   Nakashima, Shinji ^a   Mawatari, Tohru ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; INCIDENCE; LUNG CANCER; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 56249149198     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.07.016     Document Type: Article

References (28)

1. Koizumi K., Hirata T., Hirai K., Mikami I., Okada D., Yamagishi S., et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg 10 (2004) 340-346
2. Okamoto T., Gotoh M., Masuya D., Nakashima T., Liu D., Kameyama K., et al. Clinical analysis of interstitial pneumonia after surgery for lung cancer. Jpn J Thorac Cardiovasc Surg 52 (2004) 323-329
3. Utz J.P., Ryu J.H., Douglas W.W., Hartman T.E., Tazelaar H.D., Myers J.L., et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 17 (2001) 175-179
4. Martinod E., Azorin J.F., Sadoun D., Destable M.D., Le Toumelin P., Longchampt E., et al. Surgical resection of lung cancer in patients with underlying interstitial lung disease. Ann Thorac Surg 74 (2002) 1004-1007
5. Yoshimura K., Nakatani T., Nakamori Y., Chonabayashi N., Tachibana A., Nakata K., et al. [Acute exacerbation in idiopathic interstitial pneumonia.]. Nihon Kyobu Shikkan Gakkai Zasshi 22 (1984) 1012-1020 In Japanese
6. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
7. Schwartz D.A., Helmers R.A., Galvin J.R., Van Fossen D.S., Frees K.L., Dayton C.S., et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149 (1994) 450-454
8. Hubbard R., Johnston I., and Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 113 (1998) 396-400
9. Mapel D.W., Hunt W.C., Utton R., Baumgartner K.B., Samet J.M., and Coultas D.B. Related idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax 53 (1998) 469-476
10. Hubbard R., Venn A., Lewis S., and Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161 (2000) 5-8
11. Hojo S., Fujita J., Yamadori I., Kamei T., Yoshinouchi T., Ohtsuki Y., et al. Heterogeneous point mutations of the p53 gene in pulmonary fibrosis. Eur Respir J 12 (1998) 1404-1408
12. Mapel D.W., Hunt W.C., Utton R., Baumgartner K.B., Samet J.M., and Coultas D.B. Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax 53 (1998) 469-476
13. Bjoraker J.A., Ryu J.H., Edwin M.K., Myers J.L., Tazelaar H.D., Schroeder D.R., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 (1998) 199-203
14. Meyer E.C., and Liebow A.A. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer 18 (1965) 322-351
15. Mizushima Y., and Kobayashi M. Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese cases. Chest 108 (1995) 1272-1277
16. Kumar P., Goldstraw P., Yamada K., Nicholson A.G., Wells A.U., Hansell D.M., et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 125 (2003) 1321-1327
17. Kushibe K., Kawaguchi T., Takahama M., Kimura M., Tojo T., and Taniguchi S. Operative indications for lung cancer with idiopathic pulmonary fibrosis. Thorac Cardiovasc Surg 55 (2007) 505-508
18. Yano T., and Koga T. [Prophylactic administration of steroid for interstitial pneumonia after pulmonary resection for lung cancer.]. Kyobu Geka 58 (2005) 37-40 In Japanese
19. Hunninghake G.W., and Kalica A.R. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 151 (1995) 915-918
20. Douglas W.W., Ryu J.H., and Schroeder D.R. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 161 (2000) 1172-1178
21. Meyer A., Buhl R., and Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 7 (1994) 431-436
22. Misthos P., Katsaragakis S., Milingos N., Kakaris S., Sepsas E., Athanassiadi K., et al. Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation. Eur J Cardiothorac Surg 27 (2005) 379-383
23. Sakamoto S., Homma S., Kawabata M., Kono T., Seki K., Nakata K., et al. [Fatal acute exacerbation of idiopathic pulmonary fibrosis/usual interstitial pneumonia initially in the right lung after surgery lobectomy for left lung cancer.]. Nihon Kokyuki Gakkai Zasshi 42 (2004) 760-766 In Japanese
24. Inase N., Sawada M., Ohtani Y., Miyake S., Isogai S., Sakashita H., et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med 42 (2003) 565-570
25. Yoshida M., Taguchi O., Gabazza E.C., Yasui H., Kobayashi T., Kobayashi H., et al. The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis. Eur Respir J 10 (1997) 2051-2054
26. Takeuchi E., Yamaguchi T., Mori M., Tanaka S., Nakagawa M., Yokota S., et al. [Characteristics and management of patients with lung cancer and idiopathic interstitial pneumonia.]. Nihon Kyobu Shikkan Gakkai Zasshi 34 (1996) 653-658 In Japanese
27. Chang A.Y., Kuebler J.P., Tormey D.C., Anderson S., Pandya K.J., Borden E.C., et al. Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer. Cancer 57 (1986) 54-59
28. Dajczman E., Srolovitz H., Kreisman H., and Frank H. Fatal pulmonary toxicity following oral etoposide therapy. Lung Cancer 12 (1995) 81-86